This email contains graphics, if you don’t see them, view it in your browser.

Juve Patent

Dear Reader,

The dynamics between German firms show little sign of slowing. Only a year and a half ago, the patent firm Bonabry was born of a spin-off from Preu Bohlig and now it has already lined up a merger. In January 2027, Bonabry will join forces with Hamburg patent attorney firm Hamm&Wittkopp — a move expected to bolster its standing in the pharma sector. At the same time, Pinsent Masons is making a determined return to the German patent litigation stage with two Vossius partners in Düsseldorf. And, Hoffmann Eitle poaches a patent attorney from Norton Rose Fulbright to broaden its reach in hi-tech, thus continuing its steady expansion.

The momentum is also reflected in the JUVE Awards Germany nominations: alongside established names such as Clifford Chance and df-mp, spin-off boutiques Ampersand and Bonabry have made the shortlist for Patent Law Firm of the Year — proof that the newcomers are making serious progress.

This week also saw a decision in the case of G1/25. The Enlarged Board of Appeal has finally resolved the long-running quarrel over whether patent descriptions must be adapted to amended claims. Its much-awaited answer is a nuanced yes: adaptation is required where a genuine inconsistency arises, but the EPC demands no purely formal tidying-up.

Enjoy this week's read,

Mathieu Klos
Editor

News & Stories

Merger
Bonabry to merge with patent attorney firm Hamm&Wittkopp

IP boutique Bonabry is set to expand its ranks. From 1 January 2027, the firm will merge with Hamburg-based patent attorney outfit Hamm&Wittkopp. The combined entity will operate under the Bonabry brand as an integrated mixed IP litigation boutique with a strong pharmaceutical focus.

31 August 2026 by Konstanze Richter
Germany
Hoffmann Eitle hires Norton Rose Fulbright partner
1 September 2026 by Laura King
Germany
Two Vossius partners reopen German market for Pinsent Masons
28 August 2026 by Mathieu Klos
JUVE Awards 2026
JUVE announces nominees for patent awards Germany
26 August 2026 by Laura King
EPO Enlarged Board of Appeal
G1/25: Patent holders must amend patent specifications
3 September 2026 by Mathieu Klos

Trending Topics

mRNA vaccines

Case preview
The Hague local division faces hot week in mRNA litigation
1 September 2026 by Mathieu Klos
mRNA technology
The mRNA wars are escalating with new claims from Arbutus
18 August 2026 by Mathieu Klos
Show all